Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSM8 | ISIN: US87978U1088 | Ticker-Symbol: 3OS
Tradegate
28.03.24
19:10 Uhr
3,560 Euro
-0,060
-1,66 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
TEMPEST THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
TEMPEST THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,5803,72028.03.
3,5403,70028.03.

Aktuelle News zur TEMPEST THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.03.Tempest Therapeutics Inc reports results for the quarter ended in December - Earnings Summary7
19.03.Tempest Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans3
19.03.Tempest Therapeutics GAAP EPS of -$1.91 beats by $0.032
19.03.Tempest Therapeutics, Inc. - 10-K, Annual Report1
19.03.Tempest Therapeutics: Tempest Reports Year End 2023 Financial Results and Provides Business Update60Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of careReported new biomarker data in two...
► Artikel lesen
19.03.Tempest Therapeutics, Inc. - 8-K, Current Report2
05.03.Tempest Therapeutics: Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting21
02.02.Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)360BRISBANE, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted...
► Artikel lesen
05.01.Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)234BRISBANE, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted...
► Artikel lesen
01.12.23Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)587BRISBANE, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted...
► Artikel lesen
20.11.23Tempest Therapeutics: Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference41
17.11.23Tempest Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans12
09.11.23Tempest Therapeutics stock rallies in wake of business update27
09.11.23Tempest Therapeutics Inc reports results for the quarter ended in September - Earnings Summary43
08.11.23Tempest Therapeutics, Inc. - 10-Q, Quarterly Report10
08.11.23Tempest Therapeutics: Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update286TPST-1120 demonstrates superiority compared to standard of care across multiple study endpoints in randomized first-line HCC studyNew capital strengthens balance sheet and extends cash runway into...
► Artikel lesen
08.11.23Tempest Therapeutics, Inc. - 8-K, Current Report2
17.10.23What's Going On With Tempest Therapeutics Stock Today?134
16.10.23Tempest Therapeutics continues wild ride as stock rallies 80%129
13.10.23Pre-market Movers: T2 Biosystems, Outset Medical, Tempest Therapeutics, Cassava Sciences, SMART Global Holdings1.492BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.20 A.M. ET).In the Green Scienjoy Holding Corporation (SJ) is up over 11% at...
► Artikel lesen
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,23